As of now, 24 laboratories in 11 states and two foreign countries are believed to have received suspect samples, the Pentagon said.» Read More
Biotech investors are going to be busy with new data on Alzheimer's drugs, cancer and genetic disorders on the way. Here's what analysts are watching.
Drugmaker Teva is considering making a bid for Mylan, but has not yet made a decision on an offer, Dow Jones reported.
Consumer advocates worry a new trade deal could could make generic drugs harder to bring to market, reports The Fiscal Times.
For Pfizer and Merck, two big names that have ridden the merger wave, buying up more business is a possibility, their CEOs said.
A company says it can help states protect Obamacare subsidies for residents by setting up an insurance exchange in just two months.
After an abrupt departure, Former Teva CEO Jeremy Levin is now leading a start-up focused on rare neurological disorders.
Democrat Jared Bernstein says Chris Christie's Social Security plan "does virtually nothing" to make the program solvent.
Obamacare scared some companies, but their CEOs have been pleasantly surprised with how insurance prices have actually risen since 2011.
Thomas Terry has the "Best Job of 2015." And you know what question he gets asked all the time? "How long am I going to live?"
Wednesday's tax deadline features some new Obamacare-related chores that need to be completed.
Australia is making it harder for parents to file personal objections against vaccination.
After millions of people get hit with the Obamacare tax penalty, the real pain will hit. And it's a gift to Republicans, says Jake Novak.
People newly covered by Medicaid drove a significant increase in prescription drug use in 2014, reports The New York Times.
IBM is teaming with Apple, J&J and Medtronic in hopes of revolutionizing the health care industry.
Johnson & Johnson reports quarterly earnings that beat expectations despite a 7.2 percent drag on the strong dollar.
The rate of people without health coverage has reached a record low, dropping to 11.9 percent since the launch of Obamacare.
Several high-ranking bankers have left their jobs at major investment banks in the last 13 months amid a surge in U.S. health care deal activity.
Meet MEDi, the friendly robot designed to make painful procedures such as blood tests or vaccines stress-free for children.
About half the people who received federal money to help pay for their Obamacare insurance will repay some of that money this tax season.
It can cost $75,000 to $250,000, and the names keep getting stranger as companies balance regulator concerns with the desire to market the product.
Get the best of CNBC in your inbox